CRISPR Therapeutics AG CRSP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 3:12 PM EDT
79.71quote price arrow up+1.05 (+1.33%)
Volume
571,248
52 week range
42.51 - 129.50
Loading...
  • Open78.59
  • Day High80.00
  • Day Low77.06
  • Prev Close78.66
  • 52 Week High129.50
  • 52 Week High Date09/01/21
  • 52 Week Low42.51
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap6.218B
  • Shares Out78.01M
  • 10 Day Average Volume1.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.93
  • YTD % Change5.44

KEY STATS

  • Open78.59
  • Day High80.00
  • Day Low77.06
  • Prev Close78.66
  • 52 Week High129.50
  • 52 Week High Date09/01/21
  • 52 Week Low42.51
  • 52 Week Low Date05/12/22
  • Market Cap6.218B
  • Shares Out78.01M
  • 10 Day Average Volume1.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.93
  • YTD % Change5.44

RATIOS/PROFITABILITY

  • EPS (TTM)-8.23
  • P/E (TTM)-9.68
  • Fwd P/E (NTM)-8.68
  • EBITDA (TTM)-608.886M
  • ROE (TTM)-26.99%
  • Revenue (TTM)14.82M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,274.02%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date10/30/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CRISPR Therapeutics AG

There is no recent news for this security.

Profile

MORE
CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which allows for precise directed changes to genomic deoxyribonucleic acid (DNA). The Company has a portfolio of therapeutic programs in a range of disease areas, including...
Rodger Novak M.D.
Chairman of the Board, President, Co-Founder
Samarth Kulkarni Ph.D.
Chief Executive Officer, Director
Lawrence Klein Ph.D.
Chief Operating Officer
Brendan Smith
Chief Financial Officer
James Kasinger J.D.
General Counsel, Secretary
Address
Baarerstrasse 14
Zug
6300
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
ASND
Ascendis Pharma A/S
107.89-2.33-2.12%
CERE
Cerevel Therapeutics Holdings Inc
34.02-0.84-2.41%
NTLA
Intellia Therapeutics Inc
68.29+0.55+0.81%
APLS
Apellis Pharmaceuticals Inc
68.63+0.68+1.00%
BEAM
Beam Therapeutics Inc
70.57+1.49+2.16%